Clovis Oncology, Inc. (NASDAQ:CLVS) 1Q18 earnings preview

Clovis Oncology, Inc. (NASDAQ:CLVS) is reporting first quarter financial results on Tuesday 8th May 2018, after the bell.

According to analysts surveyed by Thomson Reuters, CLVS is expected to report 1Q18 loss of $ 1.36 per share from revenue of $ 18.33 million.

The same period from last year, CLVS reportedly had loss of $ 1.33 per share on $ 7.04 million in revenue.

For the full year, analysts anticipate top line of $ 148.80 million, while looking forward to loss of $ 4.81 per share bottom line.

()
()

About Clovis Oncology, Inc.

CLVS
Name
Change
% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Volume
Dividend Rate

Be the first to comment

Leave a Reply